Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

盘后交易 08-12 17:09:35 EDT

0.7320

+0.0445

+6.47%

盘后0.7300

-0.0020-0.27%

17:01 EDT

最高0.7377	最低0.6700	成交量168.51万
今开0.7065	昨收0.6875	日振幅9.85%
总市值2.16亿	流通市值1.55亿	总股本2.95亿
成交额119.18万	换手率0.79%	流通股本2.12亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":0.732,"timestamp":1786564800000,"preClose":0.6875,"halted":0,"volume":1685079,"hourTrading":{"tag":"盘后","latestPrice":0.73,"preClose":0.732,"latestTime":"17:01 EDT","volume":2593,"amount":1897.7529121999999,"timestamp":1786568487924,"change":-0.002,"changeRate":-0.002732,"amplitude":0.002732},"delay":0,"changeRate":0.0647272727272727,"floatShares":212310657,"shares":295000000,"eps":-0.353273,"marketStatus":"盘后交易","change":0.0445,"latestTime":"08-12 17:09:35 EDT","open":0.7065,"high":0.7377,"low":0.67,"amount":1191806.3298537,"amplitude":0.098473,"askPrice":0.74,"askSize":2500,"bidPrice":0.68,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.353273,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786579200000},"marketStatusCode":4,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":0.6875,"preHourTrading":{"tag":"盘前","latestPrice":0.715,"preClose":0.6875,"latestTime":"09:29 EDT","volume":2180,"amount":1556.62791,"timestamp":1786541383848,"change":0.0275,"changeRate":0.04,"amplitude":0.047273},"postHourTrading":{"tag":"盘后","latestPrice":0.73,"preClose":0.732,"latestTime":"17:01 EDT","volume":2593,"amount":1897.7529121999999,"timestamp":1786568487924,"change":-0.002,"changeRate":-0.002732,"amplitude":0.002732},"volumeRatio":0.547973,"impliedVol":3.0939,"impliedVolPercentile":0.9721},"requestUrl":"/m/hq/s/IVVD/tweets","defaultTab":"tweets","newsList":[{"id":"1108163420","title":"Invivyd 收到Pemgarda®紧急使用授权终止的12个月预先通知 并就后续与美国FDA的步骤提供更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1108163420","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108163420?lang=zh_cn&edition=full","pubTime":"2026-07-06 19:03","pubTimestamp":1783335806,"startTime":"0","endTime":"0","summary":"Invivyd公司宣布，已收到关于其药物Pemgarda®紧急使用授权（EUA）将被终止的12个月预先通知，同时就下一步与美国食品药品监督管理局（FDA）的沟通计划提供了最新进展。\n该通知意味着，针对Pemgarda的紧急使用授权将在通知期满后正式终止。公司表示，正在积极评估这一情况，并已与FDA展开讨论，以明确后续的监管路径和可能的选择方案。\nInvivyd强调，将继续致力于推进其研发管线，并与监管机构保持密切合作，以应对当前的监管环境变化。公司计划在获得更多明确信息后，向投资者和市场提供进一步的更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146587076","title":"Invivyd宣布完成评估Vyd2311抗体与mRNA新冠疫苗的3期Liberty试验入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1146587076","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146587076?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:02","pubTimestamp":1781607758,"startTime":"0","endTime":"0","summary":"Invivyd公司宣布，其评估Vyd2311抗体与mRNA新冠疫苗对比的3期Liberty试验已完成患者入组工作。该试验旨在比较Vyd2311抗体与现有mRNA疫苗在预防新冠病毒感染方面的有效性与安全性。完成入组标志着该候选疗法向获取关键临床数据迈出了重要一步，为后续的监管申请奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172130180","title":"Invivyd宣布完成扩大规模的关键三期临床试验Vyd2311患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1172130180","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172130180?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:03","pubTimestamp":1780311815,"startTime":"0","endTime":"0","summary":"Invivyd, Inc.近日宣布，其针对在研新冠预防性抗体Vyd2311开展的关键性三期临床试验“Declaration”已完成全部患者入组工作，且该试验的规模较原计划有所扩大。这项名为“Declaration”的研究是一项随机、双盲、安慰剂对照的全球性三期关键试验，旨在评估Vyd2311在预防有症状新冠病毒感染方面的有效性和安全性。此次试验的顺利完成，对于评估Vyd2311的临床潜力以及满足全球持续存在的新冠预防需求至关重要。Invivyd致力于开发创新的抗体疗法，以应对不断演变的病毒威胁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152037603","title":"Invivyd与合作者发表新论文，评估新冠单克隆抗体早期耐受性并与疫苗接种结果对比","url":"https://stock-news.laohu8.com/highlight/detail?id=1152037603","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152037603?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:02","pubTimestamp":1778497361,"startTime":"0","endTime":"0","summary":"Invivyd, Inc. 与其合作者共同撰写了一篇新的研究论文，该论文重点评估了针对新冠病毒的单克隆抗体疗法的早期耐受性情况。研究团队将所获得的临床数据与现有新冠疫苗接种后观察到的不良反应结果进行了系统性比较分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183344206","title":"Invivyd公布Revolution项目进展 推进潜在首创及最优麻疹单抗候选药物Vms063用于治疗与预防","url":"https://stock-news.laohu8.com/highlight/detail?id=1183344206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183344206?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:04","pubTimestamp":1775732653,"startTime":"0","endTime":"0","summary":"生物技术公司Invivyd, Inc.宣布，其Revolution项目取得重要进展，正加速推进新型麻疹单克隆抗体候选药物Vms063的研发。该药物具备成为同类首创及最优疗法的潜力，旨在用于麻疹的治疗与预防。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110360648","title":"Invivyd公布2025年第四季度及全年财报，披露近期业务进展与Declaration临床试验更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1110360648","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110360648?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:05","pubTimestamp":1772712305,"startTime":"0","endTime":"0","summary":"Invivyd, Inc.近日发布了2025年第四季度及全年的财务业绩报告，同时公布了公司近期的业务发展动态以及Declaration临床试验项目的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271809","title":"Invivyd, Inc.盘中异动 早盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518271809?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619349,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分，Invivyd, Inc.股票出现波动，股价大幅下挫5.59%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3551.71%、926.79%、795.06%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161369","title":"Invivyd, Inc.盘中异动 快速跳水5.86%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517161369?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:00","pubTimestamp":1741273241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时00分，Invivyd, Inc.股票出现波动，股价快速跳水5.86%。截至发稿，该股报0.998美元/股，成交量26.2609万股，换手率0.22%，振幅2.83%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948823","title":"Invivyd, Inc.盘中异动 股价大涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517948823?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:36","pubTimestamp":1741185399,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时36分，Invivyd, Inc.股票出现异动，股价大幅拉升6.67%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为390.41%、261.05%、190.80%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Invivyd, Inc.，振幅分别为23.90%、20.71%、13.32%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516305677","title":"Invivyd, Inc.盘中异动 早盘急速跳水9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516305677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098916,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Invivyd, Inc.股票出现异动，股价大幅跳水9.11%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332074","title":"Invivyd, Inc.盘中异动 早盘股价大跌7.21%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514332074?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Invivyd, Inc.股票出现异动，股价大幅跳水7.21%。截至发稿，该股报1.15美元/股，成交量11.3726万股，换手率0.10%，振幅1.60%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514338978","title":"Invivyd, Inc.盘中异动 大幅拉升5.28%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514338978?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Invivyd, Inc.股票出现波动，股价快速上涨5.28%。截至发稿，该股报1.30美元/股，成交量44.3116万股，换手率0.37%，振幅8.13%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856912","title":"Invivyd, Inc.盘中异动 股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856912?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:36","pubTimestamp":1740580583,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时36分，Invivyd, Inc.股票出现异动，股价快速下跌5.77%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514909720","title":"Invivyd, Inc.盘中异动 早盘股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514909720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514909720?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:35","pubTimestamp":1740494121,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时35分，Invivyd, Inc.股票出现波动，股价急速上涨5.55%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Adial Pharmaceuticals, Inc、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为766.29%、489.24%、253.20%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Moleculin Biotech, Inc.、Silexion Therapeutics Corp，振幅分别为20.51%、15.89%、14.67%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223521962ff366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223521962ff366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720520","title":"Invivyd, Inc.盘中异动 股价大跌27.98%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720520?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Invivyd, Inc.股票出现异动，股价大幅下挫27.98%。截至发稿，该股报1.27美元/股，成交量447.745万股，换手率3.74%，振幅9.04%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223121a2521404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223121a2521404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296578","title":"Invivyd, Inc.盘中异动 股价大涨6.20%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296578?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:34","pubTimestamp":1740148442,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时34分，Invivyd, Inc.股票出现异动，股价快速拉升6.20%。截至发稿，该股报1.29美元/股，成交量31.3387万股，换手率0.26%，振幅1.65%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223402a24eb10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223402a24eb10c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512866764","title":"Invivyd, Inc.盘中异动 早盘快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512866764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512866764?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:18","pubTimestamp":1739978334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时18分，Invivyd, Inc.股票出现异动，股价大幅跳水5.14%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为422.89%、232.88%、135.33%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、154.02%、36.97%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854a24c055f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854a24c055f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512914165","title":"Invivyd, Inc.盘中异动 大幅下挫7.76%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512914165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512914165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889301,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Invivyd, Inc.股票出现波动，股价快速下挫7.76%。截至发稿，该股报1.49美元/股，成交量77.572万股，换手率0.65%，振幅5.59%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223501a24aad99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223501a24aad99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380330","title":"Invivyd, Inc.股价重挫18.15% 市值跌2827.92万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380330?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:33","pubTimestamp":1739284409,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时33分，Invivyd, Inc.股票出现波动，股价快速下跌18.15%。截至发稿，该股报1.29美元/股，成交量186.629万股，换手率1.56%，振幅9.24%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112233309881bd3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112233309881bd3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2510863780","title":"Invivyd, Inc.盘中异动 早盘大幅下跌6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863780?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197930,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Invivyd, Inc.股票出现波动，股价快速下跌6.37%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1534.47%、848.26%、563.44%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.，振幅分别为19.19%、17.20%、16.04%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223210abc9a528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223210abc9a528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":0.1994},{"period":"1month","weight":-0.1224},{"period":"3month","weight":-0.5323},{"period":"6month","weight":-0.5507},{"period":"1year","weight":-0.1069},{"period":"ytd","weight":-0.7217}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0207},{"period":"3month","weight":0.0381},{"period":"6month","weight":0.1311},{"period":"1year","weight":0.2117},{"period":"ytd","weight":0.13}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司，其使命是快速、永久地提供基于抗体的疗法，以保护脆弱人群免受流行病毒威胁的破坏性后果，从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体（“MAB”），以跟上不断演变的病毒威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.046272},{"month":2,"riseRate":0.2,"avgChangeRate":0.346603},{"month":3,"riseRate":0.2,"avgChangeRate":-0.241584},{"month":4,"riseRate":0.4,"avgChangeRate":-0.167616},{"month":5,"riseRate":0.6,"avgChangeRate":0.15962},{"month":6,"riseRate":0.2,"avgChangeRate":-0.236153},{"month":7,"riseRate":0.6,"avgChangeRate":0.040588},{"month":8,"riseRate":0.8,"avgChangeRate":0.183887},{"month":9,"riseRate":0.6,"avgChangeRate":0.03577},{"month":10,"riseRate":0.4,"avgChangeRate":0.071726},{"month":11,"riseRate":0.4,"avgChangeRate":0.062538},{"month":12,"riseRate":0.4,"avgChangeRate":0.008789}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}